Many Americans not getting breast, cervical, colon cancer screenings
the ONA take:
According to a study published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, researchers have found that many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Specifically, results showed that among adults in the age groups recommended for screening, approximately one in four women not up to date with breast cancer screening, one in five women were not up to date with cervical cancer screening, and two in five were not up to date with colon cancer screening.
Of note, colon cancer screening rates were stagnant from 2010 to 2013 and cervical cancer screening using the Pap test in women 21 to 65 years of age was lower in 2013 than in 2000. In addition, mammography screenings changed minimally from previous years.
"It is often difficult to get patients to comply with screening tests, especially when they are uninsured or underinsured," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. However, healthcare providers need to convince patients that early screening can improve outcomes.
Many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|